Vitamin D Level in Laboratory Confirmed COVID-19 and Disease Progression
Nasim Dana, Maryam Nasirian, Golnaz Vaseghi, Kiyan Heshmat-Ghahdarijani, Behrooz Ataei, Azam Mosayebi, Amirreza Manteghinejad, Shaghayegh Haghjooy Javanmard
The Eurasian Journal of Medicine, doi:10.5152/eurasianjmed.2022.21088
Objective: There is no conclusive evidence to suggest vitamin D level can prevent or treat infection with the new coronavirus disease 2019. This study aimed to investigate the effects of serum level of vitamin D in patients with coronavirus disease 2019 on death, severity, and hospitalization duration. Materials and Methods: Baseline characteristic of patients was extracted from the Isfahan coronavirus disease 2019 registry database (I-CORE). Blood samples were taken from all patients to measure the level of vitamin D (25-hydroxyvitamin D) and categorized. The effect of 25(OH) D on death, severity, and hospitalization duration was analyzed by logistic regression. Results: Among our study patients, 5.5% had a severe deficiency of vitamin D, 23.7% deficiency, and 24.8% insufficiency. Of the 107 patients who died, 7.5% were severely deficient in vitamin D. We found that vitamin D deficiency had no significant effect on death, disease severity, and hospitalization (P > .05). However, having at least one comorbidity increased the odds of death five times after adjusting age > 60 years and gender (P < .0001). The results showed that among all comorbidities, diabetes has the greatest impact on the outcomes as it raised the odds of death, disease severity, and length of hospital stay by 2.23,1.72, and 1.48, respectively, after controlling the age > 60 and gender (P = .0002, P = .08, P = .012).
Conclusions: The mortality, disease severity, and hospitalization of coronavirus disease 2019 patients seem to be not affected by the low levels of 25(OH)D. However, the synergy between vitamin D levels and comorbidities, age, and gender could affect the outcome of coronavirus disease 2019 patients.
@ Severe deficiency (0-10), Deficiency (1-20), Insufficiency (20-30), Sufficiency (30-100), Toxicity (upper than 100). ^Sufficiency category with the highest case number was considered as reference group. & Days between admission to discharge (just for alive patients; n = 724). # Adjusted for have at least one underlying disease. *Estimated crude or adjusted odds ratio using binary logistic regression was significant if P value <.05.
References
Abrishami, Dalili, Torbati, Possible association of vitamin D status with lung involvement and outcome in patients with COVID-19: a retrospective study, Eur J Nutr,
doi:10.1007/s00394-020-02411-0Angelidi, Belanger, Lorinsky, Vitamin D status is associated With in-hospital mortality and mechanical ventilation: a cohort of COVID-19 hospitalized patients, Mayo Clin Proc,
doi:10.1016/j.mayocp.2021.01.001Biesalski, Vitamin D deficiency and co-morbidities in COVID-19 patients -A fatal relationship?, NFS J,
doi:10.3390/nu12092757Carpagnano, Lecce, Quaranta, Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19, J Endocrinol Invest,
doi:10.1007/s40618-020-01370-xCereda, Bogliolo, Klersy, Vitamin D 25OH deficiency in COVID-19 patients admitted to a tertiary referral hospital, Clin Nutr,
doi:10.1016/j.clnu.2020.10.055Cheng, Wang, Wang, Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19, J Med Virol,
doi:10.1002/jmv.25785Daneshkhah, Agrawal, Eshein, Subramanian, Roy et al., Evidence for possible association of vitamin D status with cytokine storm and unregulated inflammation in COVID-19 patients, Aging Clin Exp Res,
doi:10.1007/s40520-020-01677-yGatera, Abdulah, Musfiroh, Judistiani, Setiabudiawan, Updates on the status of vitamin D as a risk factor for respiratory distress syndrome, Adv Pharmacol Sci,
doi:10.1155/2018/8494816Gaudio, Murabito, Agodi, Montineri, Castellino et al., Vitamin D levels are reduced at the time of hospital admission in Sicilian SARS-CoV-2-Positive patients, Int J Environ Res Public Health
Gois, Ferreira, Olenski, Seguro, Vitamin D and infectious diseases: simple bystander or contributing factor?, Nutrients
Greiller, Martineau, Modulation of the immune response to respiratory viruses by vitamin D, Nutrients
Ha, Gu, Hou, Incidence, clinical characteristics and prognostic factor of patients with COVID-19: a systematic review and meta-analysis, medRxiv,
doi:10.3389/fendo.2020.567824Hastie, Pell, Sattar, Vitamin D and COVID-19 infection and mortality in UK Biobank, Eur J Nutr
Holick, Binkley, Bischoff-Ferrari, Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline, J Clin Endocrinol Metab,
doi:10.1210/jc.2011-0385Javanmard, Nasirian, Ataei, Vaseghi, Vaezi et al., Isfahan COvid-19 REgistry (I-CORE): design and methodology, J Res Med Sci,
doi:10.4103/jrms.JRMS_271_20Lim, Pranata, Huang, Yonas, Soeroto et al., Multiorgan failure With emphasis on acute kidney injury and severity of COVID-19: systematic review and meta-analysis, Can J Kidney Health Dis,
doi:10.1177/2054358120938573Luo, Liao, Shen, Li, Cheng, chinese people (corrected)
Lélu, Laffont, Delpy, Estrogen receptor α signaling in T lymphocytes is required for estradiol-mediated inhibition of Th1 and Th17 cell differentiation and protection against experimental autoimmune encephalomyelitis, J Immunol
Murai, Fernandes, Sales, Effect of a single high dose of vitamin D 3 on hospital length of stay in patients With moderate to severe COVID-19, JAMA,
doi:10.1001/jama.2020.26848Pagano, Peruzzu, Ruggieri, Ortona, Gagliardi, Vitamin D and sex differences in COVID-19, Front Endocrinol
Radujkovic, Hippchen, Tiwari-Heckler, Dreher, Boxberger, Vitamin D deficiency and outcome of COVID-19 patients, Nutrients
Rehan, Torday, Peleg, 1α,25-Dihydroxy-3-epi-vitamin D3, a natural metabolite of 1α,25-dihydroxy vitamin D3: production and biological activity studies in pulmonary alveolar type II cells, Mol Genet Metab,
doi:10.1016/s1096-7192(02)00022-7Sanghera, Sapkota, Aston, Vitamin D status, gender differences, and cardiometabolic health disparities, Ann Nutr Metab
Schwalfenberg, A review of the critical role of vitamin D in the functioning of the immune system and the clinical implications of vitamin D deficiency, Mol Nutr Food Res,
doi:10.1002/mnfr.201000174Smet, Smet, Herroelen, Gryspeerdt, Martens, Serum 25(OH)D level on hospital admission associated with COVID-19 stage and mortality, Am J Clin Pathol,
doi:10.1093/ajcp/aqaa252Tehrani, Khabiri, Moradi, Mosavat, Khabiri, Evaluation of vitamin D levels in COVID-19 patients referred to Labafinejad hospital in Tehran and its relationship with disease severity and mortality, Clin Nutr ESPEN,
doi:10.1016/j.clnesp.2021.01.014Vatandost, Jahani, Afshari, Amiri, Heidarimoghadam et al., Prevalence of vitamin D deficiency in Iran: a systematic review and meta-analysis, Nutr Health,
doi:10.1177/0260106018802968Wang, Zhang, Fang, Role of vitamin D in COVID-19 infections and deaths, J Evid Based Med,
doi:10.1111/jebm.12421Xu, Yang, Chen, Luo, Zhang et al., Vitamin D alleviates lipopolysaccharide-induced acute lung injury via regulation of the reninangiotensin system, Mol Med Rep,
doi:10.3892/mmr.2017.7546{ 'indexed': {'date-parts': [[2022, 8, 11]], 'date-time': '2022-08-11T08:42:32Z', 'timestamp': 1660207352288},
'reference-count': 0,
'publisher': 'AVES Publishing Co.',
'content-domain': {'domain': [], 'crossmark-restriction': False},
'DOI': '10.5152/eurasianjmed.2022.21088',
'type': 'journal-article',
'created': {'date-parts': [[2022, 8, 11]], 'date-time': '2022-08-11T08:24:03Z', 'timestamp': 1660206243000},
'source': 'Crossref',
'is-referenced-by-count': 0,
'title': 'Vitamin D Level in Laboratory Confirmed COVID-19 and Disease Progression',
'prefix': '10.5152',
'author': [ {'given': 'Nasim', 'family': 'Dana', 'sequence': 'first', 'affiliation': []},
{ 'name': 'Applied Physiology Research Center, Cardiovascular Research Institute, Isfahan '
'University of Medical Sciences, Isfahan, Iran',
'sequence': 'first',
'affiliation': []},
{'given': 'Maryam', 'family': 'Nasirian', 'sequence': 'additional', 'affiliation': []},
{'given': 'Golnaz', 'family': 'Vaseghi', 'sequence': 'additional', 'affiliation': []},
{ 'given': 'Kiyan',
'family': 'Heshmat-Ghahdarijani',
'sequence': 'additional',
'affiliation': []},
{'given': 'Behrooz', 'family': 'Ataei', 'sequence': 'additional', 'affiliation': []},
{'given': 'Azam', 'family': 'Mosayebi', 'sequence': 'additional', 'affiliation': []},
{'given': 'Amirreza', 'family': 'Manteghinejad', 'sequence': 'additional', 'affiliation': []},
{ 'given': 'Shaghayegh',
'family': 'Haghjooy Javanmard',
'sequence': 'additional',
'affiliation': []},
{ 'name': 'Infectious Diseases and Tropical Medicine Research Center; and Epidemiology and '
'Biostatistics Department, Health School, Isfahan University of Medical Sciences, '
'Isfahan, Iran',
'sequence': 'additional',
'affiliation': []},
{ 'name': 'Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan '
'University of Medical Sciences, Isfahan, Iran',
'sequence': 'additional',
'affiliation': []},
{ 'name': 'Heart Failure Research Center,Cardiovascular Research Institute, Isfahan University '
'of Medical Sciences, Isfahan, Iran',
'sequence': 'additional',
'affiliation': []},
{ 'name': 'Infectious Diseases and Tropical Medicine Research Center, Isfahan University of '
'Medical Sciences, Isfahan, Iran',
'sequence': 'additional',
'affiliation': []},
{ 'name': 'Applied Physiology Research Center, Cardiovascular Research Institute, Isfahan '
'University of Medical Sciences, Isfahan, Iran',
'sequence': 'additional',
'affiliation': []},
{ 'name': 'Cancer Prevention Research Center, Isfahan University of Medical Sciences, Omid '
'Hospital, Isfahan, Iran',
'sequence': 'additional',
'affiliation': []},
{ 'name': 'Applied Physiology Research Center, Cardiovascular Research Institute, Isfahan '
'University of Medical Sciences, Isfahan, Iran',
'sequence': 'additional',
'affiliation': []}],
'member': '3111',
'published-online': {'date-parts': [[2022, 8, 11]]},
'container-title': 'The Eurasian Journal of Medicine',
'original-title': [],
'deposited': { 'date-parts': [[2022, 8, 11]],
'date-time': '2022-08-11T08:24:15Z',
'timestamp': 1660206255000},
'score': 1,
'resource': { 'primary': { 'URL': 'https://www.eajm.org/en/vitamin-d-level-in-laboratory-confirmed-covid-19-and-disease-progression-133414'}},
'subtitle': [],
'short-title': [],
'issued': {'date-parts': [[2022, 8, 11]]},
'references-count': 0,
'URL': 'http://dx.doi.org/10.5152/eurasianjmed.2022.21088',
'relation': {},
'ISSN': ['1308-8742'],
'subject': ['General Medicine'],
'container-title-short': 'Eurasian J Med',
'published': {'date-parts': [[2022, 8, 11]]}}
